These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 34229750)

  • 1. Integrated in silico MS-based phosphoproteomics and network enrichment analysis of RASopathy proteins.
    Montero-Bullón JF; González-Velasco Ó; Isidoro-García M; Lacal J
    Orphanet J Rare Dis; 2021 Jul; 16(1):303. PubMed ID: 34229750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RASopathies: Presentation at the Genome, Interactome, and Phenome Levels.
    Pevec U; Rozman N; Gorsek B; Kunej T
    Mol Syndromol; 2016 May; 7(2):72-9. PubMed ID: 27385963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The RASopathies: Biology, genetics and therapeutic options.
    Longo JF; Carroll SL
    Adv Cancer Res; 2022; 153():305-341. PubMed ID: 35101235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The RASopathies: from pathogenetics to therapeutics.
    Hebron KE; Hernandez ER; Yohe ME
    Dis Model Mech; 2022 Feb; 15(2):. PubMed ID: 35178568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rasopathies - dysmorphic syndromes with short stature and risk of malignancy.
    Cizmarova M; Kostalova L; Pribilincova Z; Lasabova Z; Hlavata A; Kovacs L; Ilencikova D
    Endocr Regul; 2013 Oct; 47(4):217-22. PubMed ID: 24156711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RASopathies: The musculoskeletal consequences and their etiology and pathogenesis.
    Fowlkes JL; Thrailkill KM; Bunn RC
    Bone; 2021 Nov; 152():116060. PubMed ID: 34144233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copy number variants including RAS pathway genes-How much RASopathy is in the phenotype?
    Lissewski C; Kant SG; Stark Z; Schanze I; Zenker M
    Am J Med Genet A; 2015 Nov; 167A(11):2685-90. PubMed ID: 25974318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the gene-disease association of 19 genes with the RASopathies using the ClinGen gene curation framework.
    Grant AR; Cushman BJ; Cavé H; Dillon MW; Gelb BD; Gripp KW; Lee JA; Mason-Suares H; Rauen KA; Tartaglia M; Vincent LM; Zenker M
    Hum Mutat; 2018 Nov; 39(11):1485-1493. PubMed ID: 30311384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanding the Noonan spectrum/RASopathy NGS panel: Benefits of adding NF1 and SPRED1.
    Witkowski L; Dillon MW; Murphy E; S Lebo M; Mason-Suares H
    Mol Genet Genomic Med; 2020 Apr; 8(4):e1180. PubMed ID: 32107864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RASopathies and cardiac manifestations.
    Hilal N; Chen Z; Chen MH; Choudhury S
    Front Cardiovasc Med; 2023; 10():1176828. PubMed ID: 37529712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-energy-based predictions and network modelling of RASopathy and cancer missense mutations.
    Kiel C; Serrano L
    Mol Syst Biol; 2014 May; 10(5):727. PubMed ID: 24803665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The seventh international RASopathies symposium: Pathways to a cure-expanding knowledge, enhancing research, and therapeutic discovery.
    Kontaridis MI; Roberts AE; Schill L; Schoyer L; Stronach B; Andelfinger G; Aoki Y; Axelrad ME; Bakker A; Bennett AM; Broniscer A; Castel P; Chang CA; Cyganek L; Das TK; den Hertog J; Galperin E; Garg S; Gelb BD; Gordon K; Green T; Gripp KW; Itkin M; Kiuru M; Korf BR; Livingstone JR; López-Juárez A; Magoulas PL; Mansour S; Milner T; Parker E; Pierpont EI; Plouffe K; Rauen KA; Shankar SP; Smith SB; Stevenson DA; Tartaglia M; Van R; Wagner ME; Ware SM; Zenker M
    Am J Med Genet A; 2022 Jun; 188(6):1915-1927. PubMed ID: 35266292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Craniosynostosis in patients with RASopathies: Accumulating clinical evidence for expanding the phenotype.
    Ueda K; Yaoita M; Niihori T; Aoki Y; Okamoto N
    Am J Med Genet A; 2017 Sep; 173(9):2346-2352. PubMed ID: 28650561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe Noonan syndrome phenotype associated with a germline Q71R MRAS variant: a recurrent substitution in RAS homologs in various cancers.
    Suzuki H; Takenouchi T; Uehara T; Takasago S; Ihara S; Yoshihashi H; Kosaki K
    Am J Med Genet A; 2019 Aug; 179(8):1628-1630. PubMed ID: 31173466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular genetics of RASopathies: An update on novel disease genes and new disorders.
    Tartaglia M; Aoki Y; Gelb BD
    Am J Med Genet C Semin Med Genet; 2022 Dec; 190(4):425-439. PubMed ID: 36394128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The RASopathy Family: Consequences of Germline Activation of the RAS/MAPK Pathway.
    Tajan M; Paccoud R; Branka S; Edouard T; Yart A
    Endocr Rev; 2018 Oct; 39(5):676-700. PubMed ID: 29924299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First International Conference on RASopathies and Neurofibromatoses in Asia: Identification and advances of new therapeutics.
    Rauen KA; Alsaegh A; Ben-Shachar S; Berman Y; Blakeley J; Cordeiro I; Elgersma Y; Evans DG; Fisher MJ; Frayling IM; George J; Huson SM; Kerr B; Khire U; Korf B; Legius E; Messiaen L; van Minkelen R; Nampoothiri S; Ngeow J; Parada LF; Phadke S; Pillai A; Plotkin SR; Puri R; Raji A; Ramesh V; Ratner N; Shankar SP; Sharda S; Tambe A; Vikkula M; Widemann BC; Wolkenstein P; Upadhyaya M
    Am J Med Genet A; 2019 Jun; 179(6):1091-1097. PubMed ID: 30908877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of RASopathy-associated mutations on CNS development in mice and humans.
    Kang M; Lee YS
    Mol Brain; 2019 Nov; 12(1):96. PubMed ID: 31752929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonreentrant atrial tachycardia occurs independently of hypertrophic cardiomyopathy in RASopathy patients.
    Levin MD; Saitta SC; Gripp KW; Wenger TL; Ganesh J; Kalish JM; Epstein MR; Smith R; Czosek RJ; Ware SM; Goldenberg P; Myers A; Chatfield KC; Gillespie MJ; Zackai EH; Lin AE
    Am J Med Genet A; 2018 Aug; 176(8):1711-1722. PubMed ID: 30055033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignancy in Noonan syndrome and related disorders.
    Smpokou P; Zand DJ; Rosenbaum KN; Summar ML
    Clin Genet; 2015 Dec; 88(6):516-22. PubMed ID: 25683281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.